Articles
Steps to Compliance: How Best to Prepare for Russia’s 2020 Pharma Regulations
Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world.
With the global market expected to...
Articles
Data Collection in Phase II-III Clinical Research – It is Ripe for Disruption?
Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems.
Industry leaders, such as Janet Woodcock, of the FDA's Centre for...
Articles
Why AI in Drug Discovery has Yet to Live Up to its Promise!
Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted.
Despite rumours the age of the ‘blockbuster’ drug might be over, we’re currently seeing record...
Articles
First step to Secondary Packaging: Start with the End in Mind
No matter if it is meeting the needs of a rapidly aging market, blocking drug counterfeiters or differentiating your pharmaceutical product in the market, a secondary packaging program is essential to achieve success. However, pharma and biotech companies tend...
Articles
The Essential Role of Interactive Response Technology (IRT) in Clinical Trial Supply
Increasingly elaborate international clinical trials are demanding a smarter, streamlined approach from supply partners and better collaboration with sponsors.
In this environment, Interactive Response Technology (IRT) systems have been a staple and a powerful, practical tool for optimizing a product’s...
Articles
IoT Is the Key to Supply Chain Continuity, Visibility, and Productivity
As the global logistics and supply chain industry continues to grow — it is expected to reach $15.5 trillion by 2023 — pharmaceutical companies are facing more hurdles than ever to monitor their cargo as it passes through the...
Articles
The Highest Safety for Highly Potent Pharmaceuticals
Biotechnologically manufactured drugs are one of the most important pharmaceutical trends of the past years. Especially in cancer therapy, the advent of antibody-drug conjugates (ADCs) has opened the door for new, extremely promising treatment options.
But these medications are also...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read